Vanderbilt Institute of Chemical Biology

Therapeutic Approaches: Biologics, Small Molecules, Biomarkers

Therapeutic Areas of Expertise: Cardiology, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Oncology, Pain, Regenerative Medicine

Center/Program Highlights:VICB provides infrastructure for high-throughput screening, chemical synthesis and antibody and recombinant protein generation/analysis. It also has active programs in biomarker development and metabolomics based on NMR and mass spectrometry. Data management and computational/informatic resources are available for all projects.

Sources of Funding: Federal/State, Philanthropy, Industry Partnerships, Disease Foundations, University, Revenue

Website

Institutional Affiliation(s): Vanderbilt University, Vanderbilt University School of Medicine

Address:
2200 Pierce Ave
896 Preston Bldg
Nashville
Tennessee, 37232-0146
United States

Center/Program Start Date: 2002

Number of Employees: 30